Carbon monoxide-Releasing Molecule-2 (CORM-2) attenuates acute hepatic ischemia reperfusion injury in rats

BMC Gastroenterology - Tập 10 - Trang 1-9 - 2010
Yunwei Wei1,2, Ping Chen3, Marco de Bruyn2, Weihui Zhang1, Edwin Bremer2, Wijnand Helfrich1,2
1Third department of General Surgery, First Clinical Hospital Harbin, Harbin Medical University, Harbin, China
2Department of Surgery, Surgical Research Laboratories, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
3Department of Hepatobiliary Cancer Surgery, Tianjin Medical University Cancer Hospital and City Key Laboratory of Cancer Prevention and Therapy, Tianjin, China

Tóm tắt

Hepatic ischemia-reperfusion injury (I/Ri) is a serious complication occurring during liver surgery that may lead to liver failure. Hepatic I/Ri induces formation of reactive oxygen species, hepatocyte apoptosis, and release of pro-inflammatory cytokines, which together causes liver damage and organ dysfunction. A potential strategy to alleviate hepatic I/Ri is to exploit the potent anti-inflammatory and cytoprotective effects of carbon monoxide (CO) by application of so-called CO-releasing molecules (CORMs). Here, we assessed whether CO released from CORM-2 protects against hepatic I/Ri in a rat model. Forty male Wistar rats were randomly assigned into four groups (n = 10). Sham group underwent a sham operation and received saline. I/R group underwent hepatic I/R procedure by partial clamping of portal structures to the left and median lobes with a microvascular clip for 60 minutes, yielding ~70% hepatic ischemia and subsequently received saline. CORM-2 group underwent the same procedure and received 8 mg/kg of CORM-2 at time of reperfusion. iCORM-2 group underwent the same procedure and received iCORM-2 (8 mg/kg), which does not release CO. Therapeutic effects of CORM-2 on hepatic I/Ri was assessed by measuring serum damage markers AST and ALT, liver histology score, TUNEL-scoring of apoptotic cells, NFkB-activity in nuclear liver extracts, serum levels of pro-inflammatory cytokines TNF-α and IL-6, and hepatic neutrophil infiltration. A single systemic infusion with CORM-2 protected the liver from I/Ri as evidenced by a reduction in serum AST/ALT levels and an improved liver histology score. Treatment with CORM-2 also up-regulated expression of the anti-apoptotic protein Bcl-2, down-regulated caspase-3 activation, and significantly reduced the levels of apoptosis after I/Ri. Furthermore, treatment with CORM-2 significantly inhibited the activity of the pro-inflammatory transcription factor NF-κB as measured in nuclear extracts of liver homogenates. Moreover, CORM-2 treatment resulted in reduced serum levels of pro-inflammatory cytokines TNF-α and IL-6 and down-regulation of the adhesion molecule ICAM-1 in the endothelial cells of liver. In line with these findings, CORM-2 treatment reduced the accumulation of neutrophils in the liver upon I/Ri. Similar treatment with an inactive variant of CORM-2 (iCORM-2) did not have any beneficial effect on the extent of liver I/Ri. CORM-2 treatment at the time of reperfusion had several distinct beneficial effects on severity of hepatic I/Ri that may be of therapeutic value for the prevention of tissue damage as a result of I/Ri during hepatic surgery.

Tài liệu tham khảo

Lee WY, Lee SM: Ischemic preconditioning protects post-ischemic oxidative damage to mitochondria in rat liver. Shock. 2005, 24 (4): 370-5. 10.1097/01.shk.0000175895.33415.cd.

Sun K, Liu ZS, Sun Q: Role of mitochondria in cell apoptosis during hepatic ischemia-reperfusion injury and protective effect of ischemic postconditioning. World J Gastroenterol. 2004, 10 (13): 1934-8.

Carden DL, Granger DN: Pathophysiology of ischaemia-reperfusion injury. J Pathol. 2000, 190 (3): 255-66. 10.1002/(SICI)1096-9896(200002)190:3<255::AID-PATH526>3.0.CO;2-6.

Serracino-Inglott F, Habib NA, Mathie RT: Hepatic ischemia-reperfusion injury. Am J Surg. 2001, 181 (2): 160-6. 10.1016/S0002-9610(00)00573-0.

Selzner N, Rudiger H, Graf R, Clavien PA: Protective strategies against ischemic injury of the liver. Gastroenterology. 2003, 125 (3): 917-36. 10.1016/S0016-5085(03)01048-5.

Okajima K, Harada N, Kushimoto S, Uchiba M: Role of microthrombus formation in the development of ischemia/reperfusion-induced liver injury in rats. Thromb Haemost. 2002, 88 (3): 473-80.

Bos E, Leuvenink H, Snijder P, Kloosterhuis N, Hillebrands J, Leemans J, et al: Hydrogen Sulfide-Induced Hypometabolism Prevents Renal Ischemia/Reperfusion Injury. J Am Soc Nephrol. 2009, 20 (9): 1901-5. 10.1681/ASN.2008121269.

Kang K, Zhao M, Jiang H, Tan G, Pan S, Sun X: Role of hydrogen sulfide in hepatic ischemia-reperfusion-induced injury in rats. Liver Transpl. 2009, 15 (10): 1306-14. 10.1002/lt.21810.

Nicoud IB, Knox CD, Jones CM, Anderson CD, Pierce JM, Belous AE, et al: 2-APB protects against liver ischemia-reperfusion injury by reducing cellular and mitochondrial calcium uptake. Am J Physiol Gastrointest Liver Physiol. 2007, 293 (3): G623-G630. 10.1152/ajpgi.00521.2006.

Anderson CD, Belous A, Pierce J, Nicoud IB, Knox C, Wakata A, et al: Mitochondrial calcium uptake regulates cold preservation-induced Bax translocation and early reperfusion apoptosis. Am J Transplant. 2004, 4 (3): 352-62. 10.1111/j.1600-6143.2004.00357.x.

Acquaviva R, Lanteri R, Li Destri G, Caltabiano R, Vanella L, Lanzafame S, et al: Beneficial effects of rutin and L-arginine coadministration in a rat model of liver ischemia-reperfusion injury. Am J Physiol Gastrointest Liver Physiol. 2009, 296 (3): G664-G670. 10.1152/ajpgi.90609.2008.

Sun B, Sun Z, Jin Q, Chen X: CO-releasing molecules (CORM-2)-liberated CO attenuates leukocytes infiltration in the renal tissue of thermally injured mice. Int J Biol Sci. 2008, 4 (3): 176-83.

Su H, van Dam GM, Buis CI, Visser DS, Hesselink JW, Schuurs TA, et al: Spatiotemporal expression of heme oxygenase-1 detected by in vivo bioluminescence after hepatic ischemia in HO-1/Luc mice. Liver Transpl. 2006, 12 (11): 1634-9. 10.1002/lt.20852.

Amersi F, Shen XD, Anselmo D, Melinek J, Iyer S, Southard DJ, et al: Ex vivo exposure to carbon monoxide prevents hepatic ischemia/reperfusion injury through p38 MAP kinase pathway. Hepatology. 2002, 35 (4): 815-23. 10.1053/jhep.2002.32467.

Kaizu T, Ikeda A, Nakao A, Tsung A, Toyokawa H, Ueki S, et al: Protection of transplant-induced hepatic ischemia/reperfusion injury with carbon monoxide via MEK/ERK1/2 pathway downregulation. Am J Physiol Gastrointest Liver Physiol. 2008, 294 (1): G236-G244. 10.1152/ajpgi.00144.2007.

Kaizu T, Nakao A, Tsung A, Toyokawa H, Sahai R, Geller DA, et al: Carbon monoxide inhalation ameliorates cold ischemia/reperfusion injury after rat liver transplantation. Surgery. 2005, 138 (2): 229-35. 10.1016/j.surg.2005.06.015.

Tomiyama K, Ikeda A, Ueki S, Nakao A, Stolz DB, Koike Y, et al: Inhibition of Kupffer cell-mediated early proinflammatory response with carbon monoxide in transplant-induced hepatic ischemia/reperfusion injury in rats. Hepatology. 2008, 48 (5): 1608-20. 10.1002/hep.22482.

Otterbein LE, Bach FH, Alam J, Soares M, Tao Lu H, Wysk M, et al: Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat Med. 2000, 6 (4): 422-8. 10.1038/74680.

Lee TS, Chau LY: Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice. Nat Med. 2002, 8 (3): 240-6. 10.1038/nm0302-240.

Soares MP, Seldon MP, Gregoire IP, Vassilevskaia T, Berberat PO, Yu J, et al: Heme oxygenase-1 modulates the expression of adhesion molecules associated with endothelial cell activation. J Immunol. 2004, 172 (6): 3553-63.

Ott MC, Scott JR, Bihari A, Badhwar A, Otterbein LE, Gray DK, et al: Inhalation of carbon monoxide prevents liver injury and inflammation following hind limb ischemia/reperfusion. FASEB J. 2005, 19 (1): 106-8.

Motterlini R: Carbon monoxide-releasing molecules (CO-RMs): vasodilatory, anti-ischaemic and anti-inflammatory activities. Biochem Soc Trans. 2007, 35 (Pt 5): 1142-6.

Sun BW, Chen ZY, Chen X, Liu C: Attenuation of leukocytes sequestration by carbon monoxide-releasing molecules: liberated carbon monoxide in the liver of thermally injured mice. J Burn Care Res. 2007, 28 (1): 173-81. 10.1097/BCR.0b013E31802CA491.

Sawle P, Foresti R, Mann BE, Johnson TR, Green CJ, Motterlini R: Carbon monoxide-releasing molecules (CO-RMs) attenuate the inflammatory response elicited by lipopolysaccharide in RAW2647 murine macrophages. Br J Pharmacol. 2005, 145 (6): 800-10. 10.1038/sj.bjp.0706241.

Cepinskas G, Katada K, Bihari A, Potter RF: Carbon monoxide liberated from carbon monoxide-releasing molecule CORM-2 attenuates inflammation in the liver of septic mice. Am J Physiol Gastrointest Liver Physiol. 2008, 294 (1): G184-G191. 10.1152/ajpgi.00348.2007.

Katada K, Bihari A, Mizuguchi S, Yoshida N, Yoshikawa T, Fraser DD, et al: Carbon Monoxide Liberated from CO-Releasing Molecule (CORM-2) Attenuates Ischemia/Reperfusion (I/R)-Induced Inflammation in the Small Intestine. Inflammation. 2010, 33 (2): 92-100. 10.1007/s10753-009-9162-y.

Taniguchi M, Uchinami M, Doi K, Yoshida M, Sasaki H, Tamagawa K, et al: Edaravone reduces ischemia-reperfusion injury mediators in rat liver. J Surg Res. 2007, 137 (1): 69-74. 10.1016/j.jss.2006.06.033.

Cavalieri B, Perrelli MG, Aragno M, Mastrocola R, Corvetti G, Durazzo M, et al: Ischemic preconditioning attenuates the oxidant-dependent mechanisms of reperfusion cell damage and death in rat liver. Liver Transpl. 2002, 8 (11): 990-9. 10.1053/jlts.2002.35549.

Qian JM, Zhang H, Wu XF, Li GQ, Chen XP, Wu J: Improvement of recipient survival after small size graft liver transplantation in rats with preischemic manipulation or administering antisense against nuclear factor-kappaB. Transpl Int. 2007, 20 (9): 784-9. 10.1111/j.1432-2277.2007.00502.x.

Akamatsu Y, Haga M, Tyagi S, Yamashita K, Graca-Souza AV, Ollinger R, et al: Heme oxygenase-1-derived carbon monoxide protects hearts from transplant associated ischemia reperfusion injury. FASEB J. 2004, 18 (6): 771-2.

Neto JS, Nakao A, Kimizuka K, Romanosky AJ, Stolz DB, Uchiyama T, et al: Protection of transplant-induced renal ischemia-reperfusion injury with carbon monoxide. Am J Physiol Renal Physiol. 2004, 287 (5): F979-F989. 10.1152/ajprenal.00158.2004.

Nakao A, Kimizuka K, Stolz DB, Neto JS, Kaizu T, Choi AM, et al: Carbon monoxide inhalation protects rat intestinal grafts from ischemia/reperfusion injury. Am J Pathol. 2003, 163 (4): 1587-98.

Zuckerbraun B, Billiar T, Otterbein S, Kim P, Liu F, Choi A, et al: Carbon Monoxide Protects against Liver Failure through Nitric Oxide-induced Heme Oxygenase 1. J Exp Med. 2003, 198 (11): 1707-16. 10.1084/jem.20031003.

Colletti LM, Kunkel SL, Walz A, Burdick MD, Kunkel RG, Wilke CA, et al: The role of cytokine networks in the local liver injury following hepatic ischemia/reperfusion in the rat. Hepatology. 1996, 23 (3): 506-14. 10.1002/hep.510230315.

Lentsch AB, Yoshidome H, Cheadle WG, Miller FN, Edwards MJ: Chemokine involvement in hepatic ischemia/reperfusion injury in mice: roles for macrophage inflammatory protein-2 and KC. Hepatology. 1998, 27 (4): 1172-7. 10.1002/hep.510270440.

Vollmar B, Glasz J, Menger MD, Messmer K: Leukocytes contribute to hepatic ischemia/reperfusion injury via intercellular adhesion molecule-1-mediated venular adherence. Surgery. 1995, 117 (2): 195-200. 10.1016/S0039-6060(05)80085-6.

Marubayashi S, Oshiro Y, Maeda T, Fukuma K, Okada K, Hinoi T, et al: Protective effect of monoclonal antibodies to adhesion molecules on rat liver ischemia-reperfusion injury. Surgery. 1997, 122 (1): 45-52. 10.1016/S0039-6060(97)90263-4.

Teoh N, Field J, Farrell G: Interleukin-6 is a key mediator of the hepatoprotective and pro-proliferative effects of ischaemic preconditioning in mice. J Hepatol. 2006, 45 (1): 20-7. 10.1016/j.jhep.2006.01.039.

Jin X, Zimmers TA, Perez EA, Pierce RH, Zhang Z, Koniaris LG: Paradoxical effects of short- and long-term interleukin-6 exposure on liver injury and repair. Hepatology. 2006, 43 (3): 474-84. 10.1002/hep.21087.

Carlos TM, Harlan JM: Leukocyte-endothelial adhesion molecules. Blood. 1994, 84 (7): 2068-101.

Klintman D, Schramm R, Menger MD, Thorlacius H: Leukocyte recruitment in hepatic injury: selectin-mediated leukocyte rolling is a prerequisite for CD18-dependent firm adhesion. J Hepatol. 2002, 36 (1): 53-9. 10.1016/S0168-8278(01)00226-4.

Dold S, Laschke MW, Lavasani S, Menger MD, Thorlacius H: Cholestatic liver damage is mediated by lymphocyte function antigen-1-dependent recruitment of leukocytes. Surgery. 2008, 144 (3): 385-93. 10.1016/j.surg.2008.05.010.

Rajesh M, Pan H, Mukhopadhyay P, Batkai S, Osei-Hyiaman D, Hasko G, et al: Cannabinoid-2 receptor agonist HU-308 protects against hepatic ischemia/reperfusion injury by attenuating oxidative stress, inflammatory response, and apoptosis. J Leukoc Biol. 2007, 82 (6): 1382-9. 10.1189/jlb.0307180.

Teoh NC, Ito Y, Field J, Bethea NW, Amr D, McCuskey MK, et al: Diannexin, a novel annexin V homodimer, provides prolonged protection against hepatic ischemia-reperfusion injury in mice. Gastroenterology. 2007, 133 (2): 632-46. 10.1053/j.gastro.2007.05.027.

Hafez T, Moussa M, Nesim I, Baligh N, Davidson B, Abdul-Hadi A: The effect of intraportal prostaglandin E1 on adhesion molecule expression, inflammatory modulator function, and histology in canine hepatic ischemia/reperfusion injury. J Surg Res. 2007, 138 (1): 88-99. 10.1016/j.jss.2006.05.009.

Bradley PP, Priebat DA, Christensen RD, Rothstein G: Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol. 1982, 78 (3): 206-9. 10.1111/1523-1747.ep12506462.

Coito AJ, Buelow R, Shen XD, Amersi F, Moore C, Volk HD, et al: Heme oxygenase-1 gene transfer inhibits inducible nitric oxide synthase expression and protects genetically fat Zucker rat livers from ischemia-reperfusion injury. Transplantation. 2002, 74 (1): 96-102. 10.1097/00007890-200207150-00017.

Kato H, Amersi F, Buelow R, Melinek J, Coito AJ, Ke B, et al: Heme oxygenase-1 overexpression protects rat livers from ischemia/reperfusion injury with extended cold preservation. Am J Transplant. 2001, 1 (2): 121-8. 10.1034/j.1600-6143.2001.10205.x.

Kim H, Loughran P, Kim P, Billiar T, Zuckerbraun B: Carbon monoxide protects hepatocytes from TNF-[alpha]/Actinomycin D by inhibition of the caspase-8-mediated apoptotic pathway. Biochemical and Biophysical Research Communications. 2006, 344 (4): 1172-8. 10.1016/j.bbrc.2006.03.180.

Sun B, Zou X, Chen Y, Zhang P, Shi G: Preconditioning of carbon monoxide releasing molecule-derived CO attenuates LPS-induced activation of HUVEC. Int J Biol Sci. 2008, 4 (5): 270-8.

Srisook K, Han SS, Choi HS, Li MH, Ueda H, Kim C, et al: CO from enhanced HO activity or from CORM-2 inhibits both O2- and NO production and downregulates HO-1 expression in LPS-stimulated macrophages. Biochem Pharmacol. 2006, 71 (3): 307-18. 10.1016/j.bcp.2005.10.042.

Alaoui-Jamali M, Bismar T, Gupta A, Szarek W, Su J, Song W, et al: A Novel Experimental Heme Oxygenase-1-Targeted Therapy for Hormone-Refractory Prostate Cancer. Cancer Res. 2009, 69 (20): 8017-24. 10.1158/0008-5472.CAN-09-0419.

Vera T, Henegar J, Drummond H, Rimoldi J, Stec D: Protective Effect of Carbon Monoxide-Releasing Compounds in Ischemia-Induced Acute Renal Failure. J Am Soc Nephrol. 2005, 16 (4): 950-8. 10.1681/ASN.2004090736.

The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-230X/10/42/prepub

Thông tin
Thông tin xuất bản

BMC Gastroenterology

Tập 10

1-9

Thông tin tác giả